Promise of precision medicine bears fruit

Knowledge gained through genetic sequencing of tumors has led cancer centers to change treatment methods and sparked competition among drugmakers to develop targeted therapies. "What we're seeing is the beginning of a revolution in therapeutics," said Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD